Virtual clinical trial design features may continue after the pandemic and allow more patient participation, CBER Director Peter Marks said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
